login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
ILLUMINA INC (ILMN) Stock News
USA
- NASDAQ:ILMN -
US4523271090
-
Common Stock
102.12
USD
+2.82 (+2.84%)
Last: 10/3/2025, 8:00:02 PM
102
USD
-0.12 (-0.12%)
After Hours:
10/3/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ILMN Latest News, Press Relases and Analysis
All
Press Releases
5 days ago - By: Chartmill
Illumina Inc (NASDAQ:ILMN) Presents a Compelling Value Investment Case
3 days ago - By: Benzinga
Assessing Illumina: Insights From 9 Financial Analysts
3 days ago - By: Zacks Investment Research
- Mentions:
TMO
MYGN
QGEN
Illumina to Join Pharma Partners for CDx Development on KRAS Biomarker
4 days ago - By: Stocktwits
- Mentions:
DWSH
MODL
Illumina Stock Surged 6% Today – Here’s Why
4 days ago - By: Illumina, Inc.
Illumina launches new business to accelerate technology and data-driven discovery
5 days ago - By: Zacks Investment Research
- Mentions:
TMO
QGEN
PACB
PacBio Enters Carrier Screening Market With PureTarget Expansion
10 days ago - By: Benzinga
- Mentions:
ISRG
BAX
BDX
DHR
...
Trump Administration Review Targets Medical Supply Chain Vulnerabilities
12 days ago - By: Illumina, Inc.
Illumina advances personalized cancer care with new pharma development partnerships
17 days ago - By: Illumina, Inc.
- Mentions:
ALNY
Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine
a month ago - By: Illumina, Inc.
- Mentions:
LAB
Lancement d'Illumina® Protein Prep pour améliorer les connaissances protéomiques et faciliter les découvertes et le développement de médicaments
a month ago - By: Illumina, Inc.
- Mentions:
LAB
Illumina® Protein Prep, daha iyi ilaç keşfi ve geliştirilmesi için daha fazla proteomik içgörü sağlamak üzere piyasaya sürüldü
a month ago - By: Illumina, Inc.
- Mentions:
LAB
Illumina® Protein Prep bringt neue Erkenntnisse aus der Proteomik für eine verbesserte Arzneimittelforschung und -entwicklung
a month ago - By: Illumina, Inc.
- Mentions:
LAB
Se lanza Illumina® Protein Prep para impulsar mayores conocimientos proteómicos
a month ago - By: Zacks Investment Research
- Mentions:
CRSP
CRISPR Therapeutics (CRSP) Down 5.3% Since Last Earnings Report: Can It Rebound?
a month ago - By: Illumina, Inc.
- Mentions:
LAB
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
a month ago - By: Zacks Investment Research
Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term
Please enable JavaScript to continue using this application.